ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biopharmaceutical CRO Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-17Y17649
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharmaceutical CRO Market Research Report 2024
BUY CHAPTERS

Global Biopharmaceutical CRO Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-17Y17649
Report
October 2025
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Wuxi Biologics
Hangzhou Tigermed
Pharmaron Beijing
ICON
PPD
BioPharma Services
TriStar Technology Group
Fortrea
Medicilon
Asymchem
UBC
SanaClis
TFS HealthScience
PAREXEL

Biopharmaceutical CRO Market

The global Biopharmaceutical CRO market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, SMBs accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Biopharmaceutical CRO leading manufacturers including WuXi AppTec, WuXi Biologics, Hangzhou Tigermed, Pharmaron Beijing, ICON, PPD, BioPharma Services, TriStar Technology Group, Fortrea, Eurofins BioPharma Services, etc., dominate supply; the top five capture approximately % of global revenue, with WuXi AppTec leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Biopharmaceutical CRO market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Biopharmaceutical CRO Market Report

Report Metric Details
Report Name Biopharmaceutical CRO Market
Segment by Type
  • Full-service CRO
  • Specialized CRO
Segment by Application
  • SMBs
  • Large Enterprises
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company WuXi AppTec, WuXi Biologics, Hangzhou Tigermed, Pharmaron Beijing, ICON, PPD, BioPharma Services, TriStar Technology Group, Fortrea, Eurofins BioPharma Services, Medicilon, Asymchem, UBC, SanaClis, TFS HealthScience, Parexel
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Biopharmaceutical CRO study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Biopharmaceutical CRO Market report?

Ans: The main players in the Biopharmaceutical CRO Market are WuXi AppTec, WuXi Biologics, Hangzhou Tigermed, Pharmaron Beijing, ICON, PPD, BioPharma Services, TriStar Technology Group, Fortrea, Eurofins BioPharma Services, Medicilon, Asymchem, UBC, SanaClis, TFS HealthScience, Parexel

What are the Application segmentation covered in the Biopharmaceutical CRO Market report?

Ans: The Applications covered in the Biopharmaceutical CRO Market report are SMBs, Large Enterprises

What are the Type segmentation covered in the Biopharmaceutical CRO Market report?

Ans: The Types covered in the Biopharmaceutical CRO Market report are Full-service CRO, Specialized CRO

1 Study Coverage
1.1 Introduction to Biopharmaceutical CRO: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biopharmaceutical CRO Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Full-service CRO
1.2.3 Specialized CRO
1.3 Market Segmentation by Application
1.3.1 Global Biopharmaceutical CRO Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 SMBs
1.3.3 Large Enterprises
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biopharmaceutical CRO Revenue Estimates and Forecasts 2020-2031
2.2 Global Biopharmaceutical CRO Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Biopharmaceutical CRO Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Biopharmaceutical CRO Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Full-service CRO Market Size by Players
3.3.2 Specialized CRO Market Size by Players
3.4 Global Biopharmaceutical CRO Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Biopharmaceutical CRO Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Biopharmaceutical CRO Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Biopharmaceutical CRO Market Size by Type (2020-2031)
6.4 North America Biopharmaceutical CRO Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Biopharmaceutical CRO Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Biopharmaceutical CRO Market Size by Type (2020-2031)
7.4 Europe Biopharmaceutical CRO Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Biopharmaceutical CRO Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Biopharmaceutical CRO Market Size by Type (2020-2031)
8.4 Asia-Pacific Biopharmaceutical CRO Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Biopharmaceutical CRO Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Biopharmaceutical CRO Market Size by Type (2020-2031)
9.4 Central and South America Biopharmaceutical CRO Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Biopharmaceutical CRO Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Biopharmaceutical CRO Market Size by Type (2020-2031)
10.4 Middle East and Africa Biopharmaceutical CRO Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Biopharmaceutical CRO Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 WuXi AppTec
11.1.1 WuXi AppTec Corporation Information
11.1.2 WuXi AppTec Business Overview
11.1.3 WuXi AppTec Biopharmaceutical CRO Product Features and Attributes
11.1.4 WuXi AppTec Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.1.5 WuXi AppTec Biopharmaceutical CRO Revenue by Product in 2024
11.1.6 WuXi AppTec Biopharmaceutical CRO Revenue by Application in 2024
11.1.7 WuXi AppTec Biopharmaceutical CRO Revenue by Geographic Area in 2024
11.1.8 WuXi AppTec Biopharmaceutical CRO SWOT Analysis
11.1.9 WuXi AppTec Recent Developments
11.2 WuXi Biologics
11.2.1 WuXi Biologics Corporation Information
11.2.2 WuXi Biologics Business Overview
11.2.3 WuXi Biologics Biopharmaceutical CRO Product Features and Attributes
11.2.4 WuXi Biologics Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.2.5 WuXi Biologics Biopharmaceutical CRO Revenue by Product in 2024
11.2.6 WuXi Biologics Biopharmaceutical CRO Revenue by Application in 2024
11.2.7 WuXi Biologics Biopharmaceutical CRO Revenue by Geographic Area in 2024
11.2.8 WuXi Biologics Biopharmaceutical CRO SWOT Analysis
11.2.9 WuXi Biologics Recent Developments
11.3 Hangzhou Tigermed
11.3.1 Hangzhou Tigermed Corporation Information
11.3.2 Hangzhou Tigermed Business Overview
11.3.3 Hangzhou Tigermed Biopharmaceutical CRO Product Features and Attributes
11.3.4 Hangzhou Tigermed Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.3.5 Hangzhou Tigermed Biopharmaceutical CRO Revenue by Product in 2024
11.3.6 Hangzhou Tigermed Biopharmaceutical CRO Revenue by Application in 2024
11.3.7 Hangzhou Tigermed Biopharmaceutical CRO Revenue by Geographic Area in 2024
11.3.8 Hangzhou Tigermed Biopharmaceutical CRO SWOT Analysis
11.3.9 Hangzhou Tigermed Recent Developments
11.4 Pharmaron Beijing
11.4.1 Pharmaron Beijing Corporation Information
11.4.2 Pharmaron Beijing Business Overview
11.4.3 Pharmaron Beijing Biopharmaceutical CRO Product Features and Attributes
11.4.4 Pharmaron Beijing Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.4.5 Pharmaron Beijing Biopharmaceutical CRO Revenue by Product in 2024
11.4.6 Pharmaron Beijing Biopharmaceutical CRO Revenue by Application in 2024
11.4.7 Pharmaron Beijing Biopharmaceutical CRO Revenue by Geographic Area in 2024
11.4.8 Pharmaron Beijing Biopharmaceutical CRO SWOT Analysis
11.4.9 Pharmaron Beijing Recent Developments
11.5 ICON
11.5.1 ICON Corporation Information
11.5.2 ICON Business Overview
11.5.3 ICON Biopharmaceutical CRO Product Features and Attributes
11.5.4 ICON Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.5.5 ICON Biopharmaceutical CRO Revenue by Product in 2024
11.5.6 ICON Biopharmaceutical CRO Revenue by Application in 2024
11.5.7 ICON Biopharmaceutical CRO Revenue by Geographic Area in 2024
11.5.8 ICON Biopharmaceutical CRO SWOT Analysis
11.5.9 ICON Recent Developments
11.6 PPD
11.6.1 PPD Corporation Information
11.6.2 PPD Business Overview
11.6.3 PPD Biopharmaceutical CRO Product Features and Attributes
11.6.4 PPD Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.6.5 PPD Recent Developments
11.7 BioPharma Services
11.7.1 BioPharma Services Corporation Information
11.7.2 BioPharma Services Business Overview
11.7.3 BioPharma Services Biopharmaceutical CRO Product Features and Attributes
11.7.4 BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.7.5 BioPharma Services Recent Developments
11.8 TriStar Technology Group
11.8.1 TriStar Technology Group Corporation Information
11.8.2 TriStar Technology Group Business Overview
11.8.3 TriStar Technology Group Biopharmaceutical CRO Product Features and Attributes
11.8.4 TriStar Technology Group Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.8.5 TriStar Technology Group Recent Developments
11.9 Fortrea
11.9.1 Fortrea Corporation Information
11.9.2 Fortrea Business Overview
11.9.3 Fortrea Biopharmaceutical CRO Product Features and Attributes
11.9.4 Fortrea Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.9.5 Fortrea Recent Developments
11.10 Eurofins BioPharma Services
11.10.1 Eurofins BioPharma Services Corporation Information
11.10.2 Eurofins BioPharma Services Business Overview
11.10.3 Eurofins BioPharma Services Biopharmaceutical CRO Product Features and Attributes
11.10.4 Eurofins BioPharma Services Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Medicilon
11.11.1 Medicilon Corporation Information
11.11.2 Medicilon Business Overview
11.11.3 Medicilon Biopharmaceutical CRO Product Features and Attributes
11.11.4 Medicilon Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.11.5 Medicilon Recent Developments
11.12 Asymchem
11.12.1 Asymchem Corporation Information
11.12.2 Asymchem Business Overview
11.12.3 Asymchem Biopharmaceutical CRO Product Features and Attributes
11.12.4 Asymchem Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.12.5 Asymchem Recent Developments
11.13 UBC
11.13.1 UBC Corporation Information
11.13.2 UBC Business Overview
11.13.3 UBC Biopharmaceutical CRO Product Features and Attributes
11.13.4 UBC Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.13.5 UBC Recent Developments
11.14 SanaClis
11.14.1 SanaClis Corporation Information
11.14.2 SanaClis Business Overview
11.14.3 SanaClis Biopharmaceutical CRO Product Features and Attributes
11.14.4 SanaClis Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.14.5 SanaClis Recent Developments
11.15 TFS HealthScience
11.15.1 TFS HealthScience Corporation Information
11.15.2 TFS HealthScience Business Overview
11.15.3 TFS HealthScience Biopharmaceutical CRO Product Features and Attributes
11.15.4 TFS HealthScience Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.15.5 TFS HealthScience Recent Developments
11.16 Parexel
11.16.1 Parexel Corporation Information
11.16.2 Parexel Business Overview
11.16.3 Parexel Biopharmaceutical CRO Product Features and Attributes
11.16.4 Parexel Biopharmaceutical CRO Revenue and Gross Margin (2020-2025)
11.16.5 Parexel Recent Developments
12 Biopharmaceutical CROIndustry Chain Analysis
12.1 Biopharmaceutical CRO Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Biopharmaceutical CRO Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Biopharmaceutical CRO Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Wuxi Biologics
Hangzhou Tigermed
Pharmaron Beijing
ICON
PPD
BioPharma Services
TriStar Technology Group
Fortrea
Medicilon
Asymchem
UBC
SanaClis
TFS HealthScience
PAREXEL
List of Tables
 Table 1. Global Biopharmaceutical CRO Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Biopharmaceutical CRO Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Biopharmaceutical CRO Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Biopharmaceutical CRO Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Biopharmaceutical CRO Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Biopharmaceutical CRO Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Biopharmaceutical CRO Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Biopharmaceutical CRO by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CRO as of 2024)
 Table 11. Global Biopharmaceutical CRO Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Biopharmaceutical CRO Companies Headquarters
 Table 13. Global Biopharmaceutical CRO Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Biopharmaceutical CRO Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Biopharmaceutical CRO Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Biopharmaceutical CRO Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Biopharmaceutical CRO Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Biopharmaceutical CRO High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Biopharmaceutical CRO Growth Accelerators and Market Barriers
 Table 25. North America Biopharmaceutical CRO Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Biopharmaceutical CRO Growth Accelerators and Market Barriers
 Table 27. Europe Biopharmaceutical CRO Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Biopharmaceutical CRO Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Biopharmaceutical CRO Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Biopharmaceutical CRO Investment Opportunities and Key Challenges
 Table 31. Central and South America Biopharmaceutical CRO Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Biopharmaceutical CRO Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Biopharmaceutical CRO Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. WuXi AppTec Corporation Information
 Table 35. WuXi AppTec Description and Major Businesses
 Table 36. WuXi AppTec Product Features and Attributes
 Table 37. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. WuXi AppTec Revenue Proportion by Product in 2024
 Table 39. WuXi AppTec Revenue Proportion by Application in 2024
 Table 40. WuXi AppTec Revenue Proportion by Geographic Area in 2024
 Table 41. WuXi AppTec Biopharmaceutical CRO SWOT Analysis
 Table 42. WuXi AppTec Recent Developments
 Table 43. WuXi Biologics Corporation Information
 Table 44. WuXi Biologics Description and Major Businesses
 Table 45. WuXi Biologics Product Features and Attributes
 Table 46. WuXi Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. WuXi Biologics Revenue Proportion by Product in 2024
 Table 48. WuXi Biologics Revenue Proportion by Application in 2024
 Table 49. WuXi Biologics Revenue Proportion by Geographic Area in 2024
 Table 50. WuXi Biologics Biopharmaceutical CRO SWOT Analysis
 Table 51. WuXi Biologics Recent Developments
 Table 52. Hangzhou Tigermed Corporation Information
 Table 53. Hangzhou Tigermed Description and Major Businesses
 Table 54. Hangzhou Tigermed Product Features and Attributes
 Table 55. Hangzhou Tigermed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Hangzhou Tigermed Revenue Proportion by Product in 2024
 Table 57. Hangzhou Tigermed Revenue Proportion by Application in 2024
 Table 58. Hangzhou Tigermed Revenue Proportion by Geographic Area in 2024
 Table 59. Hangzhou Tigermed Biopharmaceutical CRO SWOT Analysis
 Table 60. Hangzhou Tigermed Recent Developments
 Table 61. Pharmaron Beijing Corporation Information
 Table 62. Pharmaron Beijing Description and Major Businesses
 Table 63. Pharmaron Beijing Product Features and Attributes
 Table 64. Pharmaron Beijing Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Pharmaron Beijing Revenue Proportion by Product in 2024
 Table 66. Pharmaron Beijing Revenue Proportion by Application in 2024
 Table 67. Pharmaron Beijing Revenue Proportion by Geographic Area in 2024
 Table 68. Pharmaron Beijing Biopharmaceutical CRO SWOT Analysis
 Table 69. Pharmaron Beijing Recent Developments
 Table 70. ICON Corporation Information
 Table 71. ICON Description and Major Businesses
 Table 72. ICON Product Features and Attributes
 Table 73. ICON Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. ICON Revenue Proportion by Product in 2024
 Table 75. ICON Revenue Proportion by Application in 2024
 Table 76. ICON Revenue Proportion by Geographic Area in 2024
 Table 77. ICON Biopharmaceutical CRO SWOT Analysis
 Table 78. ICON Recent Developments
 Table 79. PPD Corporation Information
 Table 80. PPD Description and Major Businesses
 Table 81. PPD Product Features and Attributes
 Table 82. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. PPD Recent Developments
 Table 84. BioPharma Services Corporation Information
 Table 85. BioPharma Services Description and Major Businesses
 Table 86. BioPharma Services Product Features and Attributes
 Table 87. BioPharma Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. BioPharma Services Recent Developments
 Table 89. TriStar Technology Group Corporation Information
 Table 90. TriStar Technology Group Description and Major Businesses
 Table 91. TriStar Technology Group Product Features and Attributes
 Table 92. TriStar Technology Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. TriStar Technology Group Recent Developments
 Table 94. Fortrea Corporation Information
 Table 95. Fortrea Description and Major Businesses
 Table 96. Fortrea Product Features and Attributes
 Table 97. Fortrea Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Fortrea Recent Developments
 Table 99. Eurofins BioPharma Services Corporation Information
 Table 100. Eurofins BioPharma Services Description and Major Businesses
 Table 101. Eurofins BioPharma Services Product Features and Attributes
 Table 102. Eurofins BioPharma Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Eurofins BioPharma Services Recent Developments
 Table 104. Medicilon Corporation Information
 Table 105. Medicilon Description and Major Businesses
 Table 106. Medicilon Product Features and Attributes
 Table 107. Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Medicilon Recent Developments
 Table 109. Asymchem Corporation Information
 Table 110. Asymchem Description and Major Businesses
 Table 111. Asymchem Product Features and Attributes
 Table 112. Asymchem Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Asymchem Recent Developments
 Table 114. UBC Corporation Information
 Table 115. UBC Description and Major Businesses
 Table 116. UBC Product Features and Attributes
 Table 117. UBC Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. UBC Recent Developments
 Table 119. SanaClis Corporation Information
 Table 120. SanaClis Description and Major Businesses
 Table 121. SanaClis Product Features and Attributes
 Table 122. SanaClis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. SanaClis Recent Developments
 Table 124. TFS HealthScience Corporation Information
 Table 125. TFS HealthScience Description and Major Businesses
 Table 126. TFS HealthScience Product Features and Attributes
 Table 127. TFS HealthScience Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. TFS HealthScience Recent Developments
 Table 129. Parexel Corporation Information
 Table 130. Parexel Description and Major Businesses
 Table 131. Parexel Product Features and Attributes
 Table 132. Parexel Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Parexel Recent Developments
 Table 134. Raw Materials Key Suppliers
 Table 135. Distributors List
 Table 136. Market Trends and Market Evolution
 Table 137. Market Drivers and Opportunities
 Table 138. Market Challenges, Risks, and Restraints
 Table 139. Research Programs/Design for This Report
 Table 140. Key Data Information from Secondary Sources
 Table 141. Key Data Information from Primary Sources


List of Figures
 Figure 1. Biopharmaceutical CRO Product Picture
 Figure 2. Global Biopharmaceutical CRO Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Full-service CRO Product Picture
 Figure 4. Specialized CRO Product Picture
 Figure 5. Global Biopharmaceutical CRO Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. SMBs
 Figure 7. Large Enterprises
 Figure 8. Biopharmaceutical CRO Report Years Considered
 Figure 9. Global Biopharmaceutical CRO Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Biopharmaceutical CRO Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Biopharmaceutical CRO Revenue Market Share by Region (2020-2031)
 Figure 13. Global Biopharmaceutical CRO Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Full-service CRO Revenue Market Share by Player in 2024
 Figure 16. Specialized CRO Revenue Market Share by Player in 2024
 Figure 17. Global Biopharmaceutical CRO Revenue Market Share by Type (2020-2031)
 Figure 18. Global Biopharmaceutical CRO Revenue Market Share by Application (2020-2031)
 Figure 19. North America Biopharmaceutical CRO Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players Biopharmaceutical CRO Revenue (US$ Million) in 2024
 Figure 21. North America Biopharmaceutical CRO Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America Biopharmaceutical CRO Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe Biopharmaceutical CRO Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players Biopharmaceutical CRO Revenue (US$ Million) in 2024
 Figure 28. Europe Biopharmaceutical CRO Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe Biopharmaceutical CRO Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 31. France Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 34. Russia Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Biopharmaceutical CRO Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players Biopharmaceutical CRO Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific Biopharmaceutical CRO Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific Biopharmaceutical CRO Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 43. India Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore Biopharmaceutical CRO Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America Biopharmaceutical CRO Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players Biopharmaceutical CRO Revenue (US$ Million) in 2024
 Figure 51. Central and South America Biopharmaceutical CRO Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America Biopharmaceutical CRO Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil Biopharmaceutical CRO Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina Biopharmaceutical CRO Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa Biopharmaceutical CRO Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players Biopharmaceutical CRO Revenue (US$ Million) in 2024
 Figure 57. South America Biopharmaceutical CRO Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa Biopharmaceutical CRO Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries Biopharmaceutical CRO Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel Biopharmaceutical CRO Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt Biopharmaceutical CRO Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa Biopharmaceutical CRO Revenue (2020-2025) & (US$ Million)
 Figure 63. Biopharmaceutical CRO Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Biopharmaceutical CMO CRO Market
Global International Clinical CRO Market Research Report 2024
Global Biopharmaceutical and Vaccines Market Research Report 2024
Global Microbiology CRO Service Market Research Report 2024
Global Clinical Pharmacology CRO Market Research Report 2024
Global Exosome CRO Market Research Report 2024
Global Preclinical CRO Services Market Research Report 2024
Global Drug Discovery CRO Market Research Report 2025
Global Biopharmaceutical Stock Solution Market Research Report 2024
Drug Discovery and Preclinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ortho Biological Products Market Research Report 2024
Global Biopharmaceutical Drug Delivery Technologies Market Research Report 2024
Global Veterinary CRO Market Research Report 2024
Global Biochip Products Market Research Report 2024
Drug Preclinical CRO Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biopharmaceutical Drug Delivery Devices Market Research Report 2024
Mammalian Biopharmaceutical Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
CRM Software in Pharma and Biotech Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical R D Outsourcing Services CRO Market Research Report 2024
Global Biological Assets Valuation Market Research Report 2024

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions